Tratamento das metástases no esqueleto apendicular

Resumo

As metástases ósseas podem evoluir com eventos (dor, fraturas e compressão) com os quais o cirurgião ortopédico irá se depararar independentemente da sua subespecialidade. Os conhecimentos cirúrgicos acumulados são predicativos para a prevenção de fraturas iminentes, assim como de fraturas patológicas. Apresentaremos um guia para avaliar e conduzir de forma adequada um paciente com implante ósseo para cirurgiões que não sejam especialistas na área.

Palavras-chave

neoplasias ósseas - metástases - fraturas patológicas/cirurgia - carcinoma

• Referências

• 1 Laitinen M, Ratasvuori M, Pakarinen TK. The multi-modal approach to metastatic diseases. In: Bentley G. editor. European Intructional Lectures. Berlin, Heidelberg: Springer; 2012: 35-44
• 2 Kelly M, Lee M, Clarkson P, O'Brien PJ. Metastatic disease of the long bones: a review of the health care burden in a major trauma centre. Can J Surg 2012; 55 (02) 95-98
• 3 Yong C, Onukwugha E, Mullins CD. Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer. Curr Opin Oncol 2014; 26 (03) 274-283
• 4 Brodowicz T, Hadji P, Niepel D, Diel I. Early identification and intervention matters: A comprehensive review of current evidence and recommendations for the monitoring of bone health in patients with cancer. Cancer Treat Rev 2017; 61: 23-34
• 5 Bochtler T, Krämer A. Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?. Front Oncol 2019; 9: 402
• 6 Jesus-Garcia R, Moura M, Granata Junior GS. et al. Metástase de Origem Primária desconhecida: primeira manifestação no tecido ósseo. Rev Bras Ortop 1996; 31 (11) 641-646
• 7 Morley N, Omar I. Imaging evaluation of musculoskeletal tumors. New York: Springer; 2014: 9-29
• 8 Avedian RS. Principles of musculoskeletal biopsy. Cancer Treat Res 2014; 162: 1-7
• 9 Lutz S, Berk L, Chang E. et al; American Society for Radiation Oncology (ASTRO). Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 79 (04) 965-976
• 10 Teixeira S, Branco L, Fernandes MH, Costa-Rodrigues J. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects. Mini Rev Med Chem 2019; 19 (12) 988-998
• 11 Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989; (249) 256-264
• 12 Simmons CPL, McMillan DC, McWilliams K. et al. Prognostic Tools in Patients With Advanced Cancer: A Systematic Review. J Pain Symptom Manage 2017; 53 (05) 962-970.e10
• 13 Soeharno H, Povegliano L, Choong PF. Multimodal Treatment of Bone Metastasis-A Surgical Perspective. Front Endocrinol (Lausanne) 2018; 9: 518
• 14 Jehn CF, Diel IJ, Overkamp F. et al. Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment. Anticancer Res 2016; 36 (06) 2631-2637
• 15 Narazaki DK, de Alverga Neto CC, Baptista AM, Caiero MT, de Camargo OP. Prognostic factors in pathologic fractures secondary to metastatic tumors. Clinics (São Paulo) 2006; 61 (04) 313-320
• 16 Moura M, Camargo OP. Iliotibial Tract Flap for Proximal Femur Tumor Replacemented by Megaprosthesis - Walking Without Claudication or Supports. In: 20th ISOLS General Meeting of the International Society of Limb Salvage, Athens, Greece. 2019
• 17 Errani C, Mavrogenis AF, Cevolani L. et al. Treatment for long bone metastases based on a systematic literature review. Eur J Orthop Surg Traumatol 2017; 27 (02) 205-211